Advertisement
Advertisement
Business /

Investor Relations

BYD expects its fast-charging batteries to provide a sales boost. Photo: Reuters
Electric & new energy vehicles

BYD playing catch-up with demand for fast-charging batteries

Carmaker says sales volume this year will be limited by battery production, which it is expanding by 20,000 to 30,000 units per month.

China’s private sector

With AI able to predict disease, can we treat ageing like a ‘bug’ in the system?

Hong Kong Monetary Authority (HKMA)

Mainland investors face uncertainty amid regulatory crackdown

Banking & finance

China’s Tiger Brokers reports strong results amid trading crackdown

Hong Kong trading soars 536 per cent, firm says, while making no mention of US$61 million fine from China’s market watchdog.

The Hong Kong market "continued its solid trajectory, with client assets posting double-digit growth" in the quarter, according to the firm's CEO. Photo: Handout
The Hong Kong market "continued its solid trajectory, with client assets posting double-digit growth" in the quarter, according to the firm's CEO. Photo: Handout
China’s private sector

Akeso lung cancer drug trial raises hopes in US$20b market

Ivonescimab phase three trials reduce death risk by 34 per cent, as analysts predict it could transform non-small cell lung cancer therapy.

HKEX

HKEX revamps Tech 100 Index as benchmark struggles to keep pace with AI rally

Seven firms including Hesai, Geekplus and Deepexi join the index as investors question whether local benchmarks reflect fast-rising AI sector.

Advertisement
Advertisement
Advertisement
China’s private sector

China’s biotech boom drives surge in home-grown innovative drug approvals

Domestic firms dominate China’s drug approvals amid jump in spending and out-licensing deals as regulator speeds path to market.

Chinese biotech firms struck a record US$60 billion in cross-border licensing deals in the first quarter of 2026. Photo: Getty Images
Chinese biotech firms struck a record US$60 billion in cross-border licensing deals in the first quarter of 2026. Photo: Getty Images
IPO

Hong Kong set to be ousted by Nasdaq as world’s biggest IPO market

International investors remain interested in Hong Kong tech listings due to attractive valuations, UBS and JPMorgan say.

IPO

Top Numerical Control rides fervour for aerospace to 80% IPO gain

Revenue from aviation and aerospace manufacturing equipment has accounted for around 90 per cent of its total since 2022.

Banking & finance

Hong Kong-listed firm uses AI to make nano-rockets to deliver life-saving drugs

METiS TechBio debuts on Hong Kong stock market as its CEO compares the drug design start-up to SpaceX for the pharmaceutical industry.

videocam
METiS TechBio debuts on Hong Kong stock market and raises HK$2.11 billion (US$269.5 million) from the sale of 201.23 million shares at HK$10.50 each. Photo: Jelly Tse
IPO

Chinese industrial robot maker Inovance joins Hong Kong IPO queue

Company aims to enhance internationalisation strategy with listing expected to raise up to US$2 billion.

Staff members work on a production line at Inovance in Nanjing, in east China’s Jiangsu province, on March 17, 2026. Photo: Xinhua
Staff members work on a production line at Inovance in Nanjing, in east China’s Jiangsu province, on March 17, 2026. Photo: Xinhua
IPO

China’s solar giant Sungrow revives Hong Kong IPO plan amid clean energy boom

Refiled application comes as a cluster of mainland China companies submits listing documents, signalling a pickup in the city’s IPO pipeline.

Banking & finance

Biotech-led boom as 8 China firms flock to Hong Kong’s thriving stock market

AI-powered drug developer Metis TechBio leads group that includes developers of autonomous driving technology and industrial robots.

Banking & finance

HKEX proposes halving settlement cycle to boost Hong Kong’s financial profile

Bourse operator launches a consultation on shortening the share settlement cycle to one day, aiming to implement the reform in late 2027.

If adopted, the shortened cycle will apply to equities, exchange-traded products, structured products, real estate investment trusts and listed debt securities, according to HKEX. Photo: Jonathan Wong
IPO

Sigenergy jumps 103% in Hong Kong debut on rising energy storage demand

The Shanghai-based firm’s shares closed at HK$659.50, versus its offer price of HK$324.20 after it raised US$560 million from its IPO.

Visitors learn about products at the booth of Sigenergy Technology during the Solar and Storage Live Africa 2026 in Johannesburg, South Africa, on March 25, 2026. Photo: Xinhua
Visitors learn about products at the booth of Sigenergy Technology during the Solar and Storage Live Africa 2026 in Johannesburg, South Africa, on March 25, 2026. Photo: Xinhua
Banking & finance

Global funds fuel Hong Kong IPO rebound as investors rebalance China portfolios

AI, robotics and energy storage firms make up most of the record-high IPO pipeline in Hong Kong, says Chan.

IPO

Huaqin’s US$580 million Hong Kong share sale attracts JPMorgan and UBS

The Shanghai-listed firm is selling 58.55 million shares, pricing them at a 31.2 per cent discount to their last-traded mainland stock price.

Advertisement
Advertisement
Advertisement
Banking & finance

Stricter Chinese scrutiny of offshore vehicles a blow for tech IPO candidates

Mainland’s stock market watchdog is discouraging establishment of ‘red-chip-structured’ companies in sensitive industries.

Many Chinese biotech and tech firms favour red-chip structures. Photo: Shutterstock
Many Chinese biotech and tech firms favour red-chip structures. Photo: Shutterstock
IPO

Hong Kong retains IPO crown but may lose to US mega listings over full year

Second place for IPO funds raised is Nasdaq, with US$5.65 billion from 18 listings, while the New York Stock Exchange ranks third.

Banking & finance

Chinese company to use AI-powered testing to boost profits and fast-track IVF

China’s falling fertility rate sees spike in demand for assisted reproduction as biotech firm raises US$101 million from Hong Kong listing.

videocam
Banking & finance

Insilico Medicine signs AI drug development deal with Eli Lilly

Reaching development, regulatory and commercial milestones could see value of deal hit around US$2.75 billion.

Life Star2, Insilico’s automation lab. Photo: Handout
Banking & finance

Tong Ren Tang unit pulls Hong Kong IPO in first postponement this year

Hospital-network operator delays plan to raise up to US$115 million amid tepid demand.

videocam
A view of Exchange Square in Central, where Hong Kong’s bourse operator has its headquarters, on March 13, 2026. Photo: Jelly Tse
A view of Exchange Square in Central, where Hong Kong’s bourse operator has its headquarters, on March 13, 2026. Photo: Jelly Tse
Banking & finance

HKIC, Gobi Partners and HKU launch fund to back university research start-ups

Gobi-HKU Fund I makes first bets at launch, investing in robotics and AI drug design spin-offs born from university research breakthroughs.

Hong Kong stock market

SFC prepares to inspect Hong Kong IPO listing sponsors amid quality concerns

Market regulator will soon begin inspection of investment banks amid concerns about deficiencies in listing documents and misconduct.

China’s private sector

US reshoring drive casts shadow over China’s contract drug makers, analyst says

Strong order backlogs underpin earnings through 2027, but analysts warn longer-term demand is less certain as US firms reshore production.

Despite the headwinds, there is growing interest from multinational pharmaceutical companies in partnering with Chinese biotech firms. Photo: Getty Images
Help preserve 120 years of quality journalism.
SUPPORT NOW